We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck and Co., McDonald's, Caterpillar and The Boeing Company
Read MoreHide Full Article
For Immediate Release
Chicago, IL – July 31, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (NYSE:JNJ – Free Report), Merck and Co. (NYSE:MRK – Free Report), McDonald's Corp. (NYSE:MCD – Free Report), Caterpillar Inc. (NYSE:CAT – Free Report) and The Boeing Company (NYSE:BA – Free Report).
The Dow enjoyed a strong week of gains, riding on stellar earnings results. The index declined on Monday due to a spike in bond yields, which dimmed the attraction of such safe haven stocks as telecom and utilities. But the index closed in the green on each successive day, closing Thursday at a record level. The Fed’s decision to refrain from raising rates at the end of its two-day policy meeting also lifted investor sentiment.
Last Week’s Performance
The Dow declined 0.3% on Monday, largely due to the fact that bond yields increased, leading investors to exit in utilities and telecom stocks. Also, shares of Johnson & Johnson (NYSE:JNJ – Free Report) fell 1.5%, dragging down the blue-chip index.
This was largely due to the fact that Merck and Co. (NYSE:MRK – Free Report) together with its South Korean partner Samsung Bioepis Co Ltd has started selling Renflexis, a less expensive alternative version of Johnson & Johnson's rheumatoid arthritis drug Remicade in the United States.
The index gained 0.5% on Tuesday following stellar earning results from McDonald's Corp. (NYSE:(MCD - Free Report) – Free Report) and Caterpillar Inc. (NYSE:(CAT - Free Report) – Free Report). Oil prices rose following Saudi’s decision to curb oil exports to the US. There were broad gains for technology stocks as the tech rally continued.
The index increased 0.5% on Wednesday, boosted by strong earnings results and the Fed’s decision not to raise rates at the end of its two-day meeting. Splendid second quarter earnings from The Boeing Company (NYSE:BA – Free Report) helped close the Dow at a record high.
The Dow outperformed the two other benchmarks to close at a record high on Thursday, riding on a rally in shares of Boeing Company and others . The blue-chip index gained 0.4%.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
The Zacks Analyst Blog Highlights: Johnson & Johnson, Merck and Co., McDonald's, Caterpillar and The Boeing Company
For Immediate Release
Chicago, IL – July 31, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Johnson & Johnson (NYSE:JNJ – Free Report), Merck and Co. (NYSE:MRK – Free Report), McDonald's Corp. (NYSE:MCD – Free Report), Caterpillar Inc. (NYSE:CAT – Free Report) and The Boeing Company (NYSE:BA – Free Report).
Today, Zacks is promoting its ''Buy'' stock recommendations. Get #1Stock of the Day pick for free.
Here are highlights from Friday’s Analyst Blog:
Dow 30 Stock Roundup: JNJ, MRK, MCD, CAT & BA
The Dow enjoyed a strong week of gains, riding on stellar earnings results. The index declined on Monday due to a spike in bond yields, which dimmed the attraction of such safe haven stocks as telecom and utilities. But the index closed in the green on each successive day, closing Thursday at a record level. The Fed’s decision to refrain from raising rates at the end of its two-day policy meeting also lifted investor sentiment.
Last Week’s Performance
The Dow declined 0.3% on Monday, largely due to the fact that bond yields increased, leading investors to exit in utilities and telecom stocks. Also, shares of Johnson & Johnson (NYSE:JNJ – Free Report) fell 1.5%, dragging down the blue-chip index.
This was largely due to the fact that Merck and Co. (NYSE:MRK – Free Report) together with its South Korean partner Samsung Bioepis Co Ltd has started selling Renflexis, a less expensive alternative version of Johnson & Johnson's rheumatoid arthritis drug Remicade in the United States.
The index gained 0.5% on Tuesday following stellar earning results from McDonald's Corp. (NYSE:(MCD - Free Report) – Free Report) and Caterpillar Inc. (NYSE:(CAT - Free Report) – Free Report). Oil prices rose following Saudi’s decision to curb oil exports to the US. There were broad gains for technology stocks as the tech rally continued.
The index increased 0.5% on Wednesday, boosted by strong earnings results and the Fed’s decision not to raise rates at the end of its two-day meeting. Splendid second quarter earnings from The Boeing Company (NYSE:BA – Free Report) helped close the Dow at a record high.
The Dow outperformed the two other benchmarks to close at a record high on Thursday, riding on a rally in shares of Boeing Company and others . The blue-chip index gained 0.4%.
About Zacks Equity Research
Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.
Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.
Strong Stocks that Should Be in the News
Many are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has nearly tripled the market from 1988 through 2015. Its average gain has been a stellar +26% per year.See these high-potential stocks free >>.
Get the full Report on JNJ - FREE
Get the full Report on MRK - FREE
Get the full Report on MCD – FREE
Get the full Report on CAT - FREE
Get the full Report on BA - FREE
Follow us on Twitter: https://twitter.com/zacksresearch
Join us on Facebook: https://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
https://www.zacks.com/
Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.